Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT04841317 Completed - Hypertension Clinical Trials

Mobile Technology for Blood Pressure Management

Start date: March 31, 2021
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.

NCT ID: NCT04841070 Completed - Clinical trials for Persistent Pulmonary Hypertension of the Newborn

NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn

NEUROPHON
Start date: July 25, 2021
Phase: N/A
Study type: Interventional

Neonatal pulmonary hypertension is a rare but serious condition resulting from a lack of adaptation to extra-uterine life in some newborns. In the short term, the risk of death requires rapid and appropriate management of this transient pathology. In the long term, these newborns present a greater brain vulnerability, a consequence of the pathology itself with cerebral hypoxia but also invasive and aggressive therapies. Although current scientific evidence indicates a correlation with the existence of neurological developmental disorders, the understanding of the long-term neurological outcome of these babies remains poorly documented. Better knowledge of remote neuro-psychomotor development of the critical period

NCT ID: NCT04836312 Completed - Obesity Clinical Trials

Intermittent Fasting Adherence and Self Tracking

iFAST
Start date: July 12, 2021
Phase: N/A
Study type: Interventional

This pilot study will randomize 34 patients with hypertension and obesity to either time-restricted feeding alone or a commitment device to encourage time-restricted feeding, including a commitment pledge, involvement of a supportive partner, setting of implementation intentions, and multiple daily reminder text messages. The intervention will last 12 weeks, followed by a 6-week follow-up period. The primary outcome is adherence to the IF regimen, captured via daily text message, over 18 weeks

NCT ID: NCT04836221 Completed - Hypertension Clinical Trials

Comorbidities And Reducing inEquitieS

CARES
Start date: May 5, 2021
Phase: N/A
Study type: Interventional

Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity. Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.

NCT ID: NCT04835233 Completed - Hypertension Clinical Trials

Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial

Start date: May 1, 2021
Phase: Phase 4
Study type: Interventional

In hypertensive mothers, it is common in clinical practice to substitute methyldopa for another medication, such as captopril, immediately after delivery, which may, as a consequence, cause a rebound effect or an initial lack of blood pressure control until the new medication had a more complete action. Thus, the treatment of hypertension in the puerperium is generally guided by expert opinion and recommendations for guidelines, based on non-robust evidence. OBJECTIVE: To evaluate the control of blood pressure in postpartum women with hypertensive syndromes during pregnancy with the maintenance of the continued use of previously used methyldopa compared to switching from antihypertensive regimen to the use of captopril. METHOD: Randomized, double-blind, drug controlled clinical trial. EXPECTED RESULT: better pressure control with the continued use of methyldopa.

NCT ID: NCT04835194 Completed - Hypertension Clinical Trials

Phenotypes and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With Hypertension and Diabetes

Start date: December 1, 2020
Phase:
Study type: Observational

Our study is the first multicenter study in Vietnam on clinical phenotypes of heart failure with preserved ejection fraction (HFpEF) in patients with concurrent type 2 diabetes (T2DM) and hypertension (HTN). The purpose of this study is to identify different phenotypes of the Vietnamese HFpEF-HTN-T2DM population, as well as the association of these phenotypes with long-term outcomes.

NCT ID: NCT04832048 Completed - Hypertension Clinical Trials

Modifications in Cardiovascular Risk Factors When Performing Physical Exercise in Hypertensive and Dyslipidemic Patients

ACTIVA
Start date: September 20, 2016
Phase: N/A
Study type: Interventional

Single-center, randomized, parallel-group, controlled, open-label study. The aim of the study was to evaluate the effects of an exercise training program intervention of different intensities (high intensity versus low-moderate intensity) on blood pressure reduction as a complementary strategy in hypertensive individuals being treated with at least one antihypertensive drug.

NCT ID: NCT04830449 Completed - Hypertension Clinical Trials

Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients

Start date: October 29, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate of efficacy and safety of HCP1904-2 and RLD2001-2 alone in patients with essential hypertension inadequately controlled on RLD2001-2 monotherapy.

NCT ID: NCT04830397 Completed - Ocular Hypertension Clinical Trials

Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).

Start date: March 31, 2021
Phase: Phase 2
Study type: Interventional

Evaluating the safety and tolerability of QLS-101 versus timolol maleate ophthalmic solution in glaucoma or ocular hypertension.

NCT ID: NCT04828655 Completed - Hypertension Clinical Trials

Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

To study the effects of the use of a mobile application plus recommendations based on a Mediterranean diet on the intake of micronutrients from natural sources (not drugs) on health indicators, cardiovascular parameters (blood pressure...), physical condition and body composition in a Spanish adult population.